Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Generalized Tonic-clonic Seizures”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06908356
What this trial is testing

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

Who this might be right for
Focal Onset SeizurePrimary Generalized Epilepsy
Praxis Precision Medicines 50
Not applicableStudy completedNCT02722590
What this trial is testing

Fycompa (Perampanel) in Korean Participants

Who this might be right for
Epilepsy
Eisai Korea Inc. 3,692
Large-scale testing (Phase 3)Study completedNCT03678753
What this trial is testing

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

Who this might be right for
Primary Generalized Epilepsy
SK Life Science, Inc. 169
Not applicableStudy completedNCT05147571
What this trial is testing

RNS System NAUTILUS Study

Who this might be right for
EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure
NeuroPace 100
Large-scale testing (Phase 3)Ended earlyNCT00692003
What this trial is testing

Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures

Who this might be right for
Epilepsy
Eisai Limited 21
Large-scale testing (Phase 3)Study completedNCT02408523
What this trial is testing

Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 242
Large-scale testing (Phase 3)Looking for participantsNCT05667142
What this trial is testing

Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc. 160
Testing effectiveness (Phase 2)Study completedNCT01118949
What this trial is testing

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT03754582
What this trial is testing

Intravenous Perampanel in Japanese Participants With Epilepsy

Who this might be right for
EpilepsySeizures
Eisai Co., Ltd. 21
Testing effectiveness (Phase 2)Looking for participantsNCT07130786
What this trial is testing

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Who this might be right for
SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more
Ayal A. Aizer, MD 150
Large-scale testing (Phase 3)Study completedNCT02849626
What this trial is testing

Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

Who this might be right for
Partial-Onset or Primary Generalized Tonic-Clonic Seizures
Eisai Inc. 180
Not applicableNo Longer AvailableNCT02307578
What this trial is testing

An Extended Access Program (EAP) for Perampanel

Who this might be right for
Primary Generalized Tonic-Clonic or Partial Onset SeizuresLennox Gastaut Syndrome
Eisai Inc.
Not applicableStudy completedNCT03059329
What this trial is testing

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Who this might be right for
Partial Seizures (With or Without Secondary Generalized Seizures)Primary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 3,809
Post-approval studies (Phase 4)Study completedNCT03288129
What this trial is testing

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Partial Onset SeizuresSecondarily Generalized SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 54